Senate Labor and Human Resources Committee
This article was originally published in The Gray Sheet
Executive Summary
Jane Williams, former Health Industry Manufacturers Association congressional affairs director, joins the health policy staff of Ranking Republican Nancy Kassebaum (Kan.) on Jan. 19. Williams, who was a health staffer for former Rep. Vin Weber (R-Minn.) before moving to HIMA in June ("The Gray Sheet" June 15, In Brief), is covering FDA issues for the committee. The panel's three-member health policy staff is being directed by Andrew Patzman, a former legislative assistant on Kassebaum's personal staff who will lead work on health care reform. The health group is filled out by Marty Sieg-Ross, MD, a former faculty member of Georgetown University Medical School, Washington, D.C., who has responsibility for all non-FDA Public Health Service affairs....
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.